Us Bancorp \De\ Aerie Pharmaceuticals Inc Transaction History

Us Bancorp \De\

$71.8 Billion
Q1 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 27, 2022	BUY	$6.37 - $15.23 $885 - $2,116	139 Added 3.65%	3,944 $59,000
Q2 2022 Aug 01, 2022	BUY	$4.95 - $9.16 $594 - $1,099	120 Added 3.26%	3,805 $29,000
Q1 2022 May 11, 2022	BUY	$5.64 - $9.8 $13,208 - $22,951	2,342 Added 174.39%	3,685 $34,000
Q4 2021 Feb 11, 2022	SELL	$7.02 - $13.33 $5,665 - $10,757	-807 Reduced 37.53%	1,343 $9,000
Q3 2021 Nov 10, 2021	BUY	$11.32 - $16.63 $1,856 - $2,727	164 Added 8.26%	2,150 $25,000

Q2 2021 Aug 05, 2021	BUY	$15.16 - $18.97 $773 - $967	51 Added 2.64%	1,986 $32,000
Q1 2021 Apr 28, 2021	SELL	$13.12 - $20.9 $3,266 - $5,204	-249 Reduced 11.4%	1,935 $35,000
Q4 2020 Feb 04, 2021	BUY	$9.12 - $14.49 $7,970 - $12,664	874 Added 66.72%	2,184 $30,000
Q3 2020 Nov 10, 2020	BUY	$10.46 - $14.46 $11,903 - $16,455	1,138 Added 661.63%	1,310 $16,000
Q2 2020 Aug 07, 2020	BUY	$12.0 - $16.13 $648 - $871	54 Added 45.76%	172 $3,000
Q1 2020 May 13, 2020	SELL	$11.84 - $25.52 $1,207 - $2,603	-102 Reduced 46.36%	118 $2,000
Q4 2019 Feb 04, 2020	SELL	$17.72 - $25.1 $1,080 - $1,531	-61 Reduced 21.71%	220 $5,000
Q3 2019 Nov 08, 2019	BUY	$18.41 - $28.0 $2,282 - $3,472	124 Added 78.98%	281 $5,000
Q2 2019 Aug 13, 2019	SELL	$28.97 - $48.21 $11,964 - $19,910	-413 Reduced 72.46%	157 $5,000
Q1 2019 May 08, 2019	BUY	$36.32 - $49.25 $14,782 - $20,044	407 Added 249.69%	570 $27,000
Q4 2018 Feb 13, 2019	SELL	$33.0 - $60.04 $30,921 - $56,257	-937 Reduced 85.18%	163 $6,000
Q3 2018 Nov 01, 2018	BUY	$56.15 - $73.9 $17,687 - $23,278	315 Added 40.13%	1,100 $67,000
Q2 2018 Aug 08, 2018	SELL	$47.85 - $70.45 $7,033 - $10,356	-147 Reduced 15.77%	785 $53,000
Q1 2018 May 08, 2018	BUY	$51.15 - $61.0 $8,593 - $10,248	168 Added 21.99%	932 $50,000
Q4 2017 Feb 02, 2018	BUY	$50.85 - $65.1 $13,882 - $17,772	273 Added 55.6%	764 $46,000
Q3 2017 Nov 13, 2017	BUY	$48.6 - $60.1 $23,862 - $29,509	491	491 $24,000

Others Institutions Holding AERI

# of Institutions

Shares Held

2.4M

Call Options Held

Put Options Held

View Full List

About AERIE PHARMACEUTICALS INC

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

More about AERI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account